KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fulgent Genetics (FLGT) Asset Writedowns and Impairment (2016 - 2025)

Fulgent Genetics (FLGT) has disclosed Asset Writedowns and Impairment for 11 consecutive years, with $1.9 million as the latest value for Q4 2025.

  • Quarterly Asset Writedowns and Impairment rose 25.27% to $1.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $13.9 million through Dec 2025, up 52.99% year-over-year, with the annual reading at $7.6 million for FY2025, 542.08% up from the prior year.
  • Asset Writedowns and Impairment hit $1.9 million in Q4 2025 for Fulgent Genetics, down from $9.9 million in the prior quarter.
  • In the past five years, Asset Writedowns and Impairment ranged from a high of $11.6 million in Q1 2022 to a low of -$2.5 million in Q1 2024.
  • Historically, Asset Writedowns and Impairment has averaged $3.5 million across 5 years, with a median of $2.1 million in 2021.
  • Biggest five-year swings in Asset Writedowns and Impairment: soared 15614.29% in 2021 and later plummeted 2109.73% in 2024.
  • Year by year, Asset Writedowns and Impairment stood at $4.8 million in 2021, then soared by 51.02% to $7.3 million in 2022, then tumbled by 52.7% to $3.5 million in 2023, then plummeted by 57.11% to $1.5 million in 2024, then increased by 25.27% to $1.9 million in 2025.
  • Business Quant data shows Asset Writedowns and Impairment for FLGT at $1.9 million in Q4 2025, $9.9 million in Q2 2025, and $2.1 million in Q1 2025.